Showing results (21-30 of 228) with videos related to

Sort By:
Pageof 23
Schizophrenia Research|July 16, 2024
Novel N100 area reliably captures aberrant sensory processing and is associated with neurocognition in early psychosisSiddharth N Machiraju, Jeffrey Wyss, Gregory Light, et al.
Early Intervention in Psychiatry|February 9, 2024
Negative self-reference as a component of subthreshold psychotic symptoms in clinical high-risk youthMichelle Sloan, Rebecca Sturner, Jean Addington, et al.
Current Psychiatry Reports|September 27, 2023
Recent Updates on Predicting Conversion in Youth at Clinical High Risk for PsychosisNoe Caballero, Siddharth Machiraju, Anthony Diomino, et al.
European Neuropsychopharmacology : the Journal of the European College of Neuropsychopharmacology|January 5, 2016
Effects of intranasal oxytocin on neural processing within a socially relevant neural circuitFiza Singh, Jason Nunag, Glennis Muldoon, et al.
Current Pharmaceutical Design|January 14, 2012
Ethical implications for clinical practice and future research in "at risk" individualsFiza Singh, Heline Mirzakhanian, Paolo Fusar-Poli, et al.
The American Journal of Psychiatry|May 3, 2002
Neurobiological measures of schizotypal personality disorder: defining an inhibitory endophenotype?Kristin S Cadenhead, Gregory A Light, Mark A Geyer, et al.
Early Intervention in Psychiatry|May 3, 2021
Bullying and social functioning, schemas, and beliefs among youth at clinical high risk for psychosisAmy Braun, Olga Santesteban-Echarri, Kristin S Cadenhead, et al.
Schizophrenia Research|December 13, 2023
Peripheral and central biomarkers associated with inflammation in antipsychotic naïve first episode psychosis: Pilot studiesKristin S Cadenhead, Heline Mirzakhanian, Cristian Achim, et al.
Early Intervention in Psychiatry|November 15, 2013
Substance use in clinical high risk for psychosis: a review of the literatureJean Addington, Nevicia Case, Majid M Saleem, et al.
Archives of General Psychiatry|December 6, 2006
Startle gating deficits in a large cohort of patients with schizophrenia: relationship to medications, symptoms, neurocognition, and level of functionNeal R Swerdlow, Gregory A Light, Kristin S Cadenhead, et al.
Pageof 23